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Background: The optimal management of leiomyomas during cesarean delivery is unclear. Objectives: To
assess the safety of myomectomy performed during cesarean delivery. Search strategy: PubMed, MEDLINE,
EMBASE, and Cochrane Library were searched to identify potentially relevant studies published prior to
June 30, 2012. Selection criteria: Case-control study comparing myomectomy with no myomectomy in
patients undergoing cesarean delivery. Data collection and analysis: The quality of the studies was assessed
and data were extracted independently by 2 authors. Main results: Nine studies, including 1 082 women
with leiomyomas, met the inclusion criteria; 443 (41.0%) women underwent cesarean myomectomy and
639 (59.1%) underwent cesarean delivery alone. The drop in hemoglobin after surgery was 0.30 g/dL greater
in the cesarean myomectomy group than in the control group, but the difference was not significant. The
operative time was 4.94 minutes longer in the cesarean myomectomy group, but again the difference was
not significant. The overall incidence of fever was comparable in the 2 groups. No hysterectomies were
performed in any of the included studies. Conclusions: Cesarean myomectomy may be a reasonable option
for some women with leiomyoma. However, no definite conclusion can be drawn because the data included
in the meta-analysis were of low quality.
© 2013 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.1. Introduction
Uterine leiomyomas are the most common uterine neoplasm. By
age 35, more than 60% of nonpregnant African-American women
and almost 40% of nonpregnant white women have leiomyomas iden-
tifiable by imaging [1]. Indeed, leiomyomas are found in up to 77%
of women if the uterus is examined closely at autopsy [2]. Most
leiomyomas are asymptomatic and might not need any therapy, but
some induce abnormal uterine bleeding, pain or menorrhagia, pressure
symptoms, urinary tract symptoms, infertility, anemia secondary to
chronic blood loss, and recurrent pregnancy loss. In addition, leiomyomas
can grow rapidly and continue to grow after menopause, and sarco-
matous changes might occur, which will become major indications
for aggressive management. Approximately 25% of women with
leiomyomas experience symptoms that require treatment [3].
The incidence rate of uterine leiomyomas in pregnancy varies
between 1.6% and 10.7% depending on the trimester of assessment
[4–7], with fibroids more common among women of advancing
maternal age. As cesarean rates continue to rise [8] and as the obstetric
population ages [9–11], obstetricians can expect to be confronted with
increasing myoma numbers during cesarean delivery.d Gynecology, Second Affiliated
dicine, 816 Zhenli Road, Hebei
ax: +86 22 60335086.
eration of Gynecology and Obstetrics.Cesarean myomectomy has traditionally been discouraged be-
cause of concerns about intractable hemorrhage, requiring hysterec-
tomy in extreme cases, and concerns about increased postoperative
morbidity. Women who have successfully carried a pregnancy to ce-
sarean delivery probably do not fulfill the conventional indications
for medical intervention for their fibroid. Some authors [12,13] have
challenged the traditional viewpoint, however, and suggest that myo-
mectomy may, in fact, be performed at the time of cesarean delivery
with selected patients. Reported benefits of such an approach include
reduction of the risk associated with anesthesia by decreasing the
need for subsequent operation, and reduction of the total cost [14].
The adequate management of leiomyomas, whether newly identified
or previously known, is not as straightforward as once thought.
The present review aims to assess the advantages and disadvan-
tages of myomectomy during cesarean delivery by meta-analysis of
a series of case-control studies.2. Materials and methods
PubMed, MEDLINE, EMBASE, and the Cochrane Library of System-
atic Reviews were used to identify potentially relevant studies. The
databases were searched without language restrictions, using the
keywords “cesarean delivery”, “myomectomy”, “uterine myoma”,
and “pregnancy with leiomyoma”. The proceedings of international
meetings and the reference lists of identified studies, textbooks, and
previously published reviews were also searched. The latest date forPublished by Elsevier Ireland Ltd. All rights reserved.
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by 2 authors.
Studies were included if they met the following criteria: (1) Case-
control study; (2) compared the advantages and disadvantages of
removing myomas as opposed to not removing them in women un-
dergoing cesarean delivery; (3) reported on at least 1 of the outcomes
mentioned later in this section. If the same study (conducted at
the same institution and/or by the same authors) was reported
twice in different journals, the paper published in the journal with
the highest impact factor or the most recent publication was included
in the analysis.
The following outcomes were used to compare patients undergo-
ing myomectomy during cesarean delivery with those undergoing
cesarean delivery alone: Preoperative and postoperative hemoglobin,
drop in hemoglobin, estimated blood loss, incidence of hemorrhage
(defined as a decrease in hematocrit of 10 points from the preopera-
tive value to the postoperative value), operative time (calculated
from skin incision to skin closure), length of hospital stay, frequency
of blood transfusion, incidence of fever (defined as temperature
higher than or equal to 38.0 °C), and need for hysterectomy.
The meta-analysis was performed according to recommendations
from QUORUM [15], MOOSE [16], and the Cochrane Collaboration
[17]. For dichotomous data, results for each study are described as
an odds ratio (OR) with 95% confidence intervals (CIs). For continu-
ous outcomes, a fixed-effects model was used and data were pooledRecords id
anoth
(
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Fig. 1. Flow diagram of study selecto calculate the weighted mean difference (WMD) with 95% CIs.
Some studies reported a mean change or percentage change from
baseline values, whereas other studies only reported medians and
ranges; in such instances, the median was regarded as being identical
to the mean and an estimate of the standard deviation was calculated
from the range [(range × 0.95)/4].
Heterogeneity was evaluated using the I2 statistic [18], with an I2
value of more than 50%, P b 0.01 being considered statistically signif-
icant for heterogeneity. Fixed-effect models were used if the hetero-
geneity was not significant. Otherwise, a random-effects model was
used. The Yates correction was used for outcomes with 0 events of
interest in 1 of the study groups [19,20]. Outcomes with 0 events in
either group were discarded from the meta-analysis. A funnel plot
was performed for all significant outcomes to consider the possibility
of bias. The analysis was performed using the statistical software
Review Manager (RevMan) 5.0 (Nordic Cochrane Centre, Cochrane
Collaboration, Copenhagen, Denmark).
3. Results
The search identified 9 case-control studies [12,13,21–27] that
compared the outcomes of women with uterine leiomyomas who
underwent cesarean myomectomy versus cesarean delivery alone
(Fig. 1). The analysis included 3 studies [21,24,27] in which the
control group (cesarean delivery alone) comprised women withoutentified through 
er source
n=19)
Duplicates
(n=272)
Excluded
(n=1994)
Excluded (n=228)
Case report (n=111)
Review article (n=38)
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(n=79)
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Contained no original data (n=3) 
Case report (n=11) 
Not appropriate control group 
(n=5)
Two articles attributed to the  
same study (n=2) 
tion for the systematic review.
Table 1
Description of studies included in the meta-analysis.a
First author Publication year Study design Patient numbers Mean age, y Gestational age, wk
Study group Control group Study group Control group Study group Control group
Brown [21] 1999 Retrospective 16 16 33.4 ± 3.6 24.6 ± 6.5 — —
Kwawukume [12] 2002 Prospective 12 12 33.8 ± 5.3 30.1 ± 5.0 — —
Roman [13] 2004 Retrospective 111 257 37 (23–48) 35 (17–48) 38.0 (27.3–41.6) 39.1 (24.0–42.6)
Kaymak [22] 2005 Retrospective 40 80 31.9 ± 4.5 30.8 ± 3.1 37.7 ± 2.5 37.6 ± 1.4
Hassiakos [23] 2006 Retrospective 47 94 32.1 ± 4.5 30.9 ± 3.3 37.7 ± 2.5 37.6 ± 1.4
Owolabi [24] 2007 Retrospective 14 14 32.4 ± 4.1 27.3 ± 4.2 — —
Park [25] 2009 Retrospective 97 60 32.7 ± 4.7 32.1 ± 4.6 38.3 (28.0–41.4) 38.4 (27.3–41.2)
Lin [26] 2010 Prospective 36 36 30.9 ± 4.1 30.3 ± 3.6 37.9 ± 1.2 37.8 ± 1.1
Simsek [27] 2012 Retrospective 70 70 31.9 ± 5.4 28 ± 4.3 38.1 ± 1.9 38.7 ± 1.2
a Values are given as mean ± SD or median (range).
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of patients in the control group would not be markedly altered by
the presence of a fibroid. Two of the 9 studies were prospective and
7 were retrospective. All studies included a control group but none
was randomized.
The analysis included 1 082 patients, 443 (41.0%) of whom
underwent cesareanmyomectomy and 639 (59.1%) underwent cesar-
ean delivery alone (Table 1). The mean age was similar between the
groups in 7 studies, but in 2 studies [21,24] patients who underwent
myomectomy were significantly older than patients who underwent
cesarean delivery alone, which likely reflects the association between
leiomyomas and older age. The control group and the cesarean myo-
mectomy groups were matched for gestational age in 6 studies, but in
3 studies [12,21,24] the gestational age was unknown. The descrip-
tion of parity differed between the studies, but there was no signifi-
cant difference in terms of parity between the 2 groups in any of
the studies. The leiomyomas were located at multiple sites and
spanned a large size range in most studies (Table 2).
The pre- and postoperative values for the outcomes of interest are
summarized in Table 3. Fig. 2 shows forest plots displaying the results
of the meta-analyses for the various outcome measures. Heterogeneity
between studieswas significant for drop in hemoglobin, operative time,
and length of hospital stay. The I2 valuewas greater than 50% (P b 0.01)
for all outcomemeasures. Therefore, random-effects models were used.
Eight studies reported a drop in hemoglobin; 1 study [24] was
excluded from the analysis because it was not possible to extract
data. The drop in hemoglobin levels in the cesarean myomectomy
group was 0.30 (95% CI, –0.11 to 0.71) g/dL higher than that in the
cesarean delivery group, but the difference was not significant
(P = 0.15) (Fig. 2A).
Four studies [12,21,24,26] reported the estimated blood loss,
whereas another 4 studies [13,22,23,27] reported the incidence of
hemorrhage; 1 study [25] was excluded from the analysis for lack of
data. There was no significant difference between the cesarean myo-
mectomy and the cesarean delivery groups for either estimated bloodTable 2
Type and size of removed fibroids.a
First author Fibroid type
Pedunculated Subserosal Intramural Submucosal
Kwawukume [12] 0.0% 0.0% 8.3% 0.0%
Roman [13] 23.0% 24.0% 24.0% 5.0%
Kaymak [22] 10.0% 32.5% 27.5% 5.0%
Hassiakos [23] 10.0% 38.5% 24.5% 5.0%
Owolabi [24] 0.0% 0.0% 35.7% 7.1%
Park [25] 4.1% 63.9% 21.6% 1.0%
Lin [26] 0.0% 0.0% 69.0% 31.0%
Simsek [27]b 0.0% 42.4% 45.2% 12.4%
a Brown et al. [21] reported that all types of fibroid were removed, but details were not
b Data reported by type and location in article.loss (WMD 19.37 mL; 95% CI, –13.88 to 52.61, P = 0.25) or incidence
of hemorrhage (OR 1.25; 95% CI, 0.79–1.97, P = 0.34) (Fig. 2B,C).
The operative time was 4.94 (95%, CI –3.32 to 13.21) minutes lon-
ger in the cesarean myomectomy group than in the cesarean delivery
group in 8 studies, but the difference was not significant (P = 0.24).
One study [21] did not report the operative time (Fig. 2D).
Eight studies [12,13,21–25,27] reported the length of hospital stay,
but 2 studies [12,24] did not present the data in a form amenable to
inclusion, so only 6 were meta-analyzed. There was no difference in
the length of hospital stay between the 2 groups (WMD 0.30 days;
95% CI, –0.02 to 0.63, P = 0.07) (Fig. 2E).
All 9 studies reported on blood transfusion frequency, but 3
[12,23,26] were excluded from the analysis because there was no
transfusion in either study group. There was no difference in the
blood transfusion frequency between the 2 groups (OR 1.55; 95% CI,
0.80–3.02, P = 0.20) (Fig. 2F).
Five studies [13,22,23,25,27] reported the incidence of fever. The
overall incidence was comparable in the 2 groups (OR 1.16; 95% CI,
0.67–1.99, P = 0.60) (Fig. 2G). No hysterectomy was reported in any
of the studies.
A funnel plot of the studies included in the meta-analysis was
performed for all significant outcomes. All studies were within the
95% CI and were distributed evenly across the vertical axis, implying
minimal publication bias.
4. Discussion
The majority of obstetricians have been taught not to performmyo-
mectomy during cesarean delivery because of the risks of intractable
bleeding, massive hemorrhage, and hysterectomy. The present meta-
analysis, however, suggests that the outcomes of patients with leiomy-
omas who undergo cesarean myomectomy do not differ greatly from
those undergoing cesarean delivery alone. Although the drop in hemo-
globin was 0.30 g/dL higher among women with cesarean myomecto-
my than among undergoing cesarean delivery alone, the differenceFibroid size
Multiple sites Not recorded b3 cm ≥3 cm and b6 cm ≥6 cm
91.7% 0.0% Average 6 cm
18.0% 5.0% 10.0% 10.9% 22.7%
25.0% 0.0% 5.0% 35.0% 60.0%
22.0% 0.0% Not reported
57.1% 0.0% Range 2–6 cm
8.2% 0.0% 47.40% 34.0% 18.6%
0.0% 0.0% Average 9.3 ± 3.3 cm
15% 0.0% 16.4% 57.5% 26.0%
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transfusion were not significantly different between the 2 groups.
To avoid hemorrhage during cesarean myomectomy, various
methods have been tried. The most common practice in the studies
included in the present analysis was to administrate high-dose oxytocin
intra- and postoperatively, although Lin et al. [26] and Kwawukume
[12] routinely used uterine artery occlusion and a tourniquet to control
intraoperative blood loss. Umezurike [28] also reported a dramatic de-
crease in the risk of severe hemorrhage as a result of using a tourniquet
and high-dose oxytocin in 3 women with cesarean myomectomy.
Kriplani et al. [29] reported the removal of a myoma measuring
25 × 20 × 15 cm and weighing 1.2 kg at the time of cesarean delivery,
using uterine artery ligation to control blood loss. Nine pregnant pa-
tients undergoing elective cesarean delivery with myomectomy were
treated with uterine devascularization by Desai et al. [30] with a mean
blood loss of 430 ± 97.5 mL, a mean change in hemoglobin from
11.3 ± 2.2 g/dL to 10.2 ± 1.2 g/dL, and a mean operative time of
1 hour 29 minutes ± 41 minutes. Many of the reported techniques
used to control blood loss are quite common, but as already noted
most studies included in the present meta-analysis did not require
any techniques beyond the use of oxytocin.
In extreme cases,massive blood loss can necessitate a hysterectomy,
but there were no such cases in the present review. Kim et al. [31],
however, reported a series of 110 women aged 20–43 years who
underwent cesarean myomectomy between January 2006 and
December 2008. Of these women, 100 had no complications, but 10
experienced significant complications (3 units of blood transfusion,
ileus, or hospital stay extended by 2 days). In the group with complica-
tions, 90% of patients required uterine artery embolization. There were
no hysterectomies among these patients, however, and there was no
need for reoperation. Exacoustòs et al. [6] also reported complications:
Three of 9 cases of cesarean myomectomy were complicated by severe
hemorrhage and did, in fact, require removal of the uterus.
Leaving uterine leiomyomas in place at cesarean delivery seems
like a good strategy to prevent intraoperative complications. This
may be a short-term view, however, that does not properly account
for long-term risks. Among 22 patients who underwent cesarean de-
livery, an average leiomyoma volume increase of 34% was reported
during a follow-up period of 38.5 months [32]. Of these patients,
40.9% underwent myomectomy (n = 7) or hysterectomy (n = 2)
within 6–38 months because of their symptoms [32]. Overall, uterine
leiomyomas are the most common indication for hysterectomy in the
USA. According to the National Women’s Health Information Center,
approximately 175 000 hysterectomies are performed annually for fi-
broids, and their economic impact is considerable. Estimates of the di-
rect cost of treating uterine leiomyomas have been as high as US$2.15
billion per year [33]. If the likelihood of repeat operation for recurrent
myomas is lower after cesarean myomectomy, as opposed to leaving
myomas in place for future operative treatment, removal at the time
of cesarean delivery may, in fact, be the safer and more cost-effective
course of action.
In the current study, cesarean myomectomy was performed with-
out regard to location and size of the myoma. Myomas located in mul-
tiple sites and larger myomas were reported in all studies, but only 2
studies reported comparisons between subgroups. One study [22]
compared the incidence of hemorrhage by myoma size, and there
was no statistically significant difference in any size group between
myomectomy patients and controls. Another study [25] compared
drop in hemoglobin, frequency of blood transfusion, and operative
time betweenmyomectomy and control group patients with similarly
sized myomas. The only difference was a longer operative time in the
myomectomy group, and this difference was only found for the sub-
group with myomas exceeding 6 cm.
Unfortunately, the present literature search did not provide infor-
mation on the criteria for, ormeans of, selecting appropriate candidates
for cesarean myomectomy. Kim et al. [31] found that, among women
A) Drop in hemoglobin 
B) Estimated blood loss
C) Incidence of hemorrhage
D) Operative time
E) Length of hospital stay
F) Blood transfusion frequency 
G) Incidence of fever
Fig. 2. Preoperative and postoperative parameters and outcomes for the cesarean myomectomy and cesarean delivery groups. (A) Drop in hemoglobin. (B) Estimated blood loss.
(C) Incidence of hemorrhage. (D) Operative time. (E) Length of hospital stay. (F) Blood transfusion frequency. (G) Incidence of fever.
212 D. Song et al. / International Journal of Gynecology and Obstetrics 121 (2013) 208–213who underwent cesarean myomectomy without complications, 35% of
the removedfibroidswere subserosal and 25%were intramural; by con-
trast, 10% of the removed fibroids in the groupwith complicationsweresubserosal and 90% were intramural. These findings seem to support
the recommendation from other authors [12,13] that the optimal uter-
inemyomas for removal at cesarean delivery are those which are easily
213D. Song et al. / International Journal of Gynecology and Obstetrics 121 (2013) 208–213accessible, such as subserosal or pedunculated myomas. Roman et al.
[13] recommended that intramural myomectomies should be per-
formedwith caution, andHassiakos et al. [23] suggested that intramural
myomas in the fundus, myomas located proximal to the fallopian tubes,
andmyomas located in the cornuamight not be good candidates for re-
moval at the time of cesarean delivery, as doing so may affect subse-
quent fertility. However, long-term studies of myomectomy patients
who attempted to become pregnant have shown pregnancy rates
between 40% and 60% [34]. When 95 infertile patients with uterine
fibroids were examined using magnetic resonance imaging, patients
with fibroids showed a higher frequency of uterine peristalsis during
the midluteal phase, which may contribute to infertility associated
with intramural-type fibroids [35].
The present study had several limitations. Ideally, a meta-analysis
should be based on randomized controlled trials. Unfortunately, no
such studies were available in the literature, so the present analysis
was based on retrospective and prospective controlled studies,
which may have introduced a selection bias. No definite conclusion
that myomectomy should be performed during cesarean delivery
can be drawn because the data included in the meta-analysis were
of low quality. Further limitations include the fact that the evaluation
of operative blood loss in the included papers was based on estimates
of blood loss, which are of limited reliability. In addition, it was only
possible to comment on short-term morbidity, so long-term effects
may have been missed. For example, no information was available
regarding possible adverse effects on future pregnancies. Finally, the
literature overall is limited and the present study population was
not large. This might impair the generalizability of the conclusions.
Overall, the present results suggest that myomectomy during
cesarean delivery may be a reasonable option for some patients, as
it can be safely performed without serious or life-threatening compli-
cations by experienced hands. The present meta-analysis did not
identify any hysterectomies resulting from massive hemorrhage.
However, the presence of complications in the literature means that
cesarean myomectomy might not be suitable for all patients, particu-
larly those with intramural fibroids. A detailed discussion should be
carried out with the patient regarding the associated risks, which
will depend on myoma size and location, with most risks being simi-
lar to those of a cesarean delivery. Long-term risks and benefits, espe-
cially with regard to future pregnancies, remain unclear, however,
and clarification of these issues may require a study with a large pop-
ulation or reliable design.
Conflict of interest
The authors have no conflicts of interest.
References
[1] Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative inci-
dence of uterine leiomyoma in black and white women: ultrasound evidence.
Am J Obstet Gynecol 2003;188(1):100–7.
[2] Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol
1990;94(4):435–8.
[3] Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R. A prospective
study of hypertension and risk of uterine leiomyomata. Am J Epidemiol 2005;161(7):
628–38.
[4] Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine
leiomyomas in the first trimester of pregnancy: an ultrasound-screening study.
Obstet Gynecol 2009;113(3):630–5.[5] Strobelt N, Ghidini A, CavalloneM, Pensabene I, Ceruti P, Vergani P. Natural history of
uterine leiomyomas in pregnancy. J Ultrasound Med 1994;13(5):399–401.
[6] Exacoustòs C, Rosati P. Ultrasound diagnosis of uterine myomas and complica-
tions in pregnancy. Obstet Gynecol 1993;82(1):97–101.
[7] QidwaiGI, CaugheyAB, JacobyAF. Obstetric outcomes inwomenwith sonographically
identified uterine leiomyomata. Obstet Gynecol 2006;107(2 Pt 1):376–82.
[8] Coleman-Cowger VH, Erickson K, Spong CY, Portnoy B, Croswell J, Schulkin J.
Current practice of cesarean delivery on maternal request following the 2006
state-of-the-science conference. J Reprod Med 2010;55(1–2):25–30.
[9] Baird DT, Collins J, Egozcue J, Evers LH, Gianaroli L, Leridon H, et al. Fertility and
ageing. Hum Reprod Update 2005;11(3):261–76.
[10] Heffner LJ. Advanced maternal age–how old is too old? N Engl J Med 2004;351(19):
1927–9.
[11] Leader A. Pregnancy and motherhood: The biological clock. Sex Reprod Menopause
2006;4(1):3–6.
[12] Kwawukume EY. Caesarean myomectomy. Afr J Reprod Health 2002;6(3):38–43.
[13] Roman AS, Tabsh KM. Myomectomy at time of cesarean delivery: a retrospective
cohort study. BMC Pregnancy Childbirth 2004;4(1):14.
[14] Febo G, Tessarolo M, Leo L, Arduino S, Wierdis T, Lanza L. Surgical management of
leiomyomata in pregnancy. Clin Exp Obstet Gynecol 1997;24(2):76–8.
[15] Clarke M. The QUORUM statement. Lancet 2000;355(9205):756–7.
[16] Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al.
Meta-analysis of observational studies in epidemiology: a proposal for reporting.
Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA
2000;283(15):2008–12.
[17] Clarke M, Horton R. Bringing it all together: Lancet-Cochrane collaborate on
systematic reviews. Lancet 2001;357(9270):1728.
[18] Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions
Version 5.0.2. Baltimore, MA: Cochrane Collaboration; 2008.
[19] Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospec-
tive studies of disease. J Natl Cancer Inst 1959;22(4):719–48.
[20] Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after
myocardial infarction: an overview of the randomized trials. Prog Cardiovasc
Dis 1985;27(5):335–71.
[21] Brown D, Fletcher HM, Myrie MO, Reid M. Caesarean myomectomy–a safe proce-
dure. A retrospective case controlled study. J Obstet Gynaecol 1999;19(2):139–41.
[22] Kaymak O, Ustunyurt E, Okyay RE, Kalyoncu S, Mollamahmutoglu L. Myomectomy
during cesarean section. Int J Gynecol Obstet 2005;89(2):90–3.
[23] Hassiakos D, Christopoulos P, Vitoratos N, Xarchoulakou E, Vaggos G, Papadias K.
Myomectomy during cesarean section: a safe procedure? Ann N Y Acad Sci
2006;1092:408–13.
[24] Owolabi AT, Kuti O, Loto OM, Makinde ON, Adeyemi AB. Caesareanmyomectomy -
a safe procedure: a retrospective case controlled study. Nepal J Obstet Gynaecol
2007;2(2):59–62.
[25] Park BJ, Kim YW. Safety of cesarean myomectomy. J Obstet Gynaecol Res
2009;35(5):906–11.
[26] Lin JY, Lee WL, Wang PH, Lai MJ, Chang WH, Liu WM. Uterine artery occlusion and
myomectomy for treatment of pregnant women with uterine leiomyomas who
are undergoing cesarean section. J Obstet Gynaecol Res 2010;36(2):284–90.
[27] Simsek Y, Celen S, Danisman N, Mollamahmutoğlu L. Removal of uterine fibroids
during cesarean section: a difficult therapeutic decision. Clin Exp Obstet Gynecol
2012;39(1):76–8.
[28] Umezurike CC. Caesarean myomectomy in Aba, southeastern Nigeria. Trop Doct
2008;38(3):189–90.
[29] Kriplani A, Dash BB, Mandal K, Garg P, Bhatia N. The role of uterine artery ligation
in increasing feasibility and safety of myomectomy during cesarean section.
J Gynecol Surg 2007;23:53–6.
[30] Desai BR, Patted SS, Pujar YV, Sherigar BY, Das SR, Ruge JC. A novel technique of
selective uterine devascularization before myomectomy at the time of cesarean
section: a pilot study. Fertil Steril 2010;94(1):362–4.
[31] Kim YS, Choi SD, Bae DH. Risk factors for complications in patients undergoing
myomectomy at the time of cesarean section. J Obstet Gynaecol Res 2010;36(3):
550–4.
[32] AbdRabbo SA. Stepwise uterine devascularization: a novel technique for manage-
ment of uncontrolled postpartum hemorrhage with preservation of the uterus.
Am J Obstet Gynecol 1994;171(3):694–700.
[33] Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid
tumors in the United States. Am J Obstet Gynecol 2006;195(4):955–64.
[34] Demello AB. Uterine artery embolization. AORN J 2001;73(4):790–2 [794–8,800–4].
[35] Yoshino O, Hayashi T, Osuga Y, Orisaka M, Asada H, Okuda S, et al. Decreased
pregnancy rate is linked to abnormal uterine peristalsis caused by intramural
fibroids. Hum Reprod 2010;25(10):2475–9.
